We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sponsors Seeking Treatments for Invasive Aspergillosis May Use Galactomannan Biomarker
The item has been added to your shopping cart.
Sponsors Seeking Treatments for Invasive Aspergillosis May Use Galactomannan Biomarker
Sponsors seeking to enroll patients in studies of treatments for invasive aspergillosis may use the presence of the molecule galactomannan as a probable indicator of the infection, under an FDA program to qualify biomarkers used in drug development.